Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model

Blood

Volumn 95, Issue 11, 2000, Pages 3613-3619

  Ilan, Yaron ^a   Gotsman, Israel ^b   Pines, Mark ^b   Beinart, Roy ^b   Zeira, Michael ^b   Ohana, Meir ^b   Rabbani, Elazar ^b   Engelhardt, Dean ^b   Nagler, Arnon ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; COLLAGEN; GAMMA INTERFERON; INTERLEUKIN 10; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW TRANSPLANTATION; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HISTOCHEMISTRY; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROSIS; SPLEEN CELL;

EID: 0034210688     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.11.3613     Document Type: Article

References (52)

1. Sullivan KM. Graft vs. host disease. In: Blume KG, Petts LD, eds. Clinical Bone Marrow Transplantation. New York, NY: Churchill-Livingstone; 1983:91-129.
2. Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED. Histopathology of gratt-vs.-host reaction in human recipients of marrow from HLA matched sibling donors. Trans Proc. 1974;6:367-371.
3. Woodruff IM, Hansen JA, Good RA, Santos GW, Slavin RE. The pathology of graft versus host reaction in adults receiving bone marrow transplants. Trans Proc. 1976;8:675-684.
4. Sale GE, Lerner KG, Barker EA, Shulman HM, Thomas ED. The skin biopsy in the diagnosis of acute graft versus host disease in man. Am J Pathol. 1977;89:621-635.
5. Ferrara JLM, Deeg HJ. Graft versus host disease. N Engl J Med. 1991;324:667-672.
6. Vogelsang GB. Graft versus host disease: implications from basic immunology for prophylaxis and treatment. Cancer Treat Res. 1997;77:87-97.
7. Nagler A, Barak V, Slavin S. Role of cytokines in graft versus host reaction and rejection following allogeneic bone marrow transplantation. In: Aggarwal BB, Puri RK, eds. Human Cytokines: Their Role in Disease and Therapy. Malden, MA: Blackwell Science; 1995:153-161.
8. Krenger W, Hill GR, Ferrara JLM. Cytokine cascades in graft versus host disease. Transplantation 1997;64:553-558.
9. Krenger W, Ferrara JLM. Graft versus host disease and the Th1/Th2 paradigm. Immunol Res. 1996;15:50-73.
10. Barak V, Levi-Schaffer F, Nisman B, Nagler A. Cytokine dysregulation in chronic graft versus host disease. Leuk Lymphoma. 1995;17:169-173.
11. Nagler A, Or R, Kalickman I, Slavin S, Barak V. Elevated inflammatory cytokine levels in bone marrow graft rejection. Transplantation. 1995;60: 943-948.
12. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today. 1997;18:335-343.
13. Strober W, Kelsall B, Fuss L, et al. Reciprocal IFNγ and TGFβ responses regulate the occurrence of mucosal inflammation. Immunol Today. 1997;18:61-64.
14. Ilan Y, Weksler-Zangen S, Ben-Horin S, et al. Treatment of experimental colitis through induction of oral tolerance towards colitis extracted proteins. Gastroenterology. 1998;114:4100A.
15. Hancock W, Polansli M, Zhang J, Blogg N, Weiner H. Suppression of insulitis in NOD mice by oral insulin administration is associated with selective expression of IL-4-10, TGF-β and prostaglandin E. Am J Pathol. 1995;147:1193-1197.
16. Neurath M, Kelasall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med. 1996;183:2605-2616.
17. Ilan Y, Prakash R, Davidson A, et al. Tolerization to adenoviral antigens permits long term gene expression using recombinant adenoviral vectors. J Clin Invest. 1997;99:1098-1106.
18. Takahashi M, Ilan Y, Sengupta K, Roy Chowdhury N, Roy Chowdhury J. Induction of tolerance to recombinant adenoviruses by injection into newborn rats: long term amelioration of hyperbilirubinemia in Gunn rats. J Biol Chem. 1996;271: 26,536-26,542.
19. Ilan Y, Jona VK, Sengupta K, et al. Transient immunosuppression with FK506 permits long term expression of therapeutic genes introduced into the liver using recombinant adenoviruses. Hepatology. 1997;26:949-956.
20. Ilan Y, Droguett G, Roy Chowdhury N, et al. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long term gene expression. Proc Nat Acad Sci U S A. 1997; 94:2587-2592.
21. Ilan Y, Attavar P, Takahashi M, et al. Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long term gene therapy in Gunn rats. J Clin Invest. 1996;98:2640-2647.
22. Trentham DE, Dynesius-Trentham RA, Orav EJ, et al. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993;261: 1727-1730.
23. Weiner HL, Mackin GA, Matsui M, et al. Double-blind pilot trial of oral tolerization with myelin antigen in multiple sclerosis. Science. 1993;261: 1321-1324.
24. Ilan Y, Sauter B, Roy Chowdhury N, et al. Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenovirus. Hepatology. 1998;27:1368-1376.
25. Sayegh MH, Zhang ZJ, Hancock WW, Kwok CA, Carpenter CB, Weiner HL. Downregulation of the immune response to histocomatibility antigens and prevention of sensitization by skin allografts by orally administered alloantigen. Transplantation. 1992;53:163-166.
26. Sayegh MH, Khoury SJ, Hancock WW, Weiner HL, Carpenter CB. Induction of immunity and oral tolerance with polymorphic class II major histocompatability complex alopeptides in the rat. Immunology. 1996;89:7762-7766.
27. Ghobrial RR, Hamashima T, Wang ME, Wang M, Stepkowski S, Khan B. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.A molecules. Transplantation. 1996;62:1002-1010.
28. Ilan Y, Pines M, Abadi U, et al. Oral tolerization ameliorates liver disorders associated with chronic graft versus host disease. Hepatology. 1998;28:962A.
29. Jaffe BD, Claman HN. Chronic graft versus host disease as a model for scleroderma: description of a model system. Cell Immunol. 1985;94:73-84.
30. Howell CD, De Victor D, Li J, Giorno RC. Liver T cell subsets and adhesion molecules in murine graft versus host disease. Bone Marrow Transplant. 1995;16:139-145.
31. Howell CD, Yoder TY, Vierlinng JM. Suppressor function of liver mononuclear cells isolated during chronic graft versus host disease. Cell Immunol. 1992;140:54-66.
32. Devender PD, Yunis I, Yunis EJ. Cellular typing: mixed lymphocyte response and cell-mediated lympholysis. In: Rose NR, Friedman H, Fahey JL, eds. Manual of Clinical Laboratory Immunology. 3rd ed. Washington, DC: American Society for Microbiology; 1986:847-852.
33. Bishara A, Brautbar C, Nagler A, et al. Prediction by a modified mixed lymphocyte reaction assay of graft versus host disease and graft rejection after allogeneic bone marrow transplantation. Transplantation. 1994;57:1474-1479.
34. Garscon-Barre M, Huet PM, Belgiorino J, Plourde V, Coulmbe PA. Estimation of collagen content of liver specimens: variation among animals and among hepatic lobes in cirrhotic rats. J Histochem Cytochem. 1989;37:377-381.
35. Pines M, Knopov V, Bar A. Involvement of osteopontin in egg shell formation in the laying chicken. Matrix Biol. 1996;14:765-761.
36. Pines M, Knopov V, Genina O, Lavelin I, Nagler A. Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis. J Hepatol. 1997;27:391-398.
37. Ferrara JL. Cytokine inhibitors and graft versus host disease. Ann N Y Acad Sci. 1995;770:227-236.
38. Gotsman I, Beinart R, Safadi R, et al. Oral tolerance towards hepatitis B antigens in a murine model. Gastroenterology. 1999;116:A1216.
39. Lieshman A, Garside P, Mowat A. Immunological consequences of intervention in established immune responses by feeding protien antigens. Cell Immunol. 1998;183:137-148.
40. Van Hoogstraten IMW, Blomberg BME, Boden D, Kraal G, Scheper R. Non sensitizing epicutaneous skin tests prevent subsequent induction of immune tolerance. J Invest Dermatol. 1994;102: 80-83.
41. Karpus WJ, Kennedy KJ, Smith WS, Miller SD. Inhibition of relapsing experimental autoimmune encephalomyelitis in SLJ mice by feeding the immunodoiminat PLP139-151 peptide. J Neuroscience Res. 1995;45:410-423.
42. Weiner HL, Mackin GA, Matsui M, et al. Double blind pilot trial of oral tolerization with myelin antigen in multiple sclerosis. Science. 1993;261: 1321-1324.
43. Trentham DE. Oral tolerization as a treatment of rheumatoid arthritis. Rheum Dis Clin North Am. 1998;24:525-534.
44. Strobel S, Mowat AM. Immune response to dietary antigens: oral tolerance. Immunol Today. 1998;4:173-181.
45. Von Herrath MG. Bystander suppression induced by oral tolerance. Res Immunol. 1997;148:541-548.
46. Miller A, Lider O, Weiner HL. Antigen bystander suppression after oral administration of antigens. J Exp Med. 1991;174:791-798.
47. Lundin BS, Dahlgren UIH, Hanson LA, Telemo E. Oral tolerization leads to active suppression and bystander tolerance in adult rats while energy dominates in young rats. Scand J Immunol. 1996; 43:46-63.
48. Sprent J, Kosaka H, Gao EK, Surh CD, Webb SR. Intrathymic and extrathymic tolerance in bone marrow chimeras. Immunol Rev. 1993;133: 151-176.
49. Ferrara JLM. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 1993;5:794-799.
50. Toren A, Novick D, Or R, Ackerstein A, Slavin A, Nagler A. Soluble interleukin 6 receptors in hematology patients undergoing bone marrow transplantation. Transplantation. 1996;62:138-147.
51. Toren A, Novick D, Ackerstein A, Or R, Slavin S, Nagler A. Soluble IL6 receptors in hematological patients receiving immunotherapy with IL2/IFNγ or donor lymphocytes following bone marrow transplantation. Bone Marrow Transplant. 1996; 18:721-724.
52. Toren A, Barak V, Novick D, Nagler A. Soluble interferon γ receplor and interferon in patients undergoing allogeneic bone marrow transplantation for hematological malignancies. Cytokines Cell Mol Ther. 1997;3:153-158